Home
KLRS

KLRS

Kalaris Therapeutics Inc. Common Stock

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Founded:	2019	Country:	United States
Employees:	N/A	City:	N/A
Market Cap:	57.5M	IPO Year:	N/A
Target Price:	N/A	AVG Volume (30 days):	18.2K
Analyst Decision:	N/A	Number of Analysts:	N/A
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-10.44	EPS Growth:	N/A
52 Week Low/High:	$7.96 - $24.15	Next Earning Date:	05-15-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

Compare KLRS vs Leading Stocks

KLRS VS BOLD

KLRS VS NHTC

KLRS VS JMM

KLRS VS NSTS

KLRS VS CATO

KLRS VS CUE

KLRS VS VIVK

KLRS VS SNAL

Share on Social Networks:

Free KLRS Stock Widget

Embed our stock ticker widget on your website.

Stock Traders Forum

Community for stock traders to ask questions, gain insights, and learn.

Stock Alerts on Telegram

Subscribe to our Telegram channel for stock tips & insights.

Similar to KLRS Stocks:

Disclaimer

The information presented on this page, "KLRS Kalaris Therapeutics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.